Alzamend Neuro, Inc. (ALZN)

NASDAQ: ALZN · IEX Real-Time Price · USD
0.980
+0.020 (2.07%)
At close: Aug 8, 2022 4:00 PM
0.999
+0.019 (1.949%)
After-hours: Aug 8, 2022 6:59 PM EDT

Cash Flow Statement (Quarterly)

Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Quarter Ended 2022-04-302022-01-312021-10-312021-07-312021-04-302021-01-312020-10-312020-07-312020-04-30
Net Income
-3.87-2.57-3.6-2.32-1.26-1.12-1.35-1.32-1.26
Depreciation & Amortization
000000000
Share-Based Compensation
1.261.131.280.740.30.580.650.510.14
Other Operating Activities
1.05-0.340.270.36-0.3-0.260.260.610.92
Operating Cash Flow
-1.56-1.78-2.05-1.22-1.26-0.81-0.44-0.21-0.2
Capital Expenditures
-0.1100000000
Acquisitions
00000000.10
Investing Cash Flow
-0.110000000.10
Share Issuance / Repurchase
40014.912.100.100.01
Debt Issued / Paid
-0.060001.050.840.290.08-0.02
Financing Cash Flow
3.940014.913.150.840.390.08-0.01
Net Cash Flow
2.27-1.78-2.0513.691.890.03-0.06-0.03-0.2
Free Cash Flow
-1.67-1.78-2.05-1.22-1.26-0.81-0.44-0.21-0.2
Free Cash Flow Per Share
-0.02-0.02-0.02-0.01-0.02-0.01-0.01-0.00-0.00
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).